Literature DB >> 1551438

Increase of poly(ADP-ribose) polymerase mRNA levels during TPA-induced differentiation of human lymphocytes.

M Menegazzi1, H Suzuki, A Carcereri de Prati, M Tommasi, M Miwa, G Gandini, F Gerosa.   

Abstract

The non-mitogenic stimulation of human peripheral blood mononuclear cells (PBMC) with low concentrations of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA) caused a progressive increase in the percent fraction of the cells that were positive for the early activating antigen CD69. At the same time, it caused a progressive increase in the steady-state levels of poly(ADP-ribose) polymerase (pADPRP) transcripts. A further increase in TPA concentration, while inducing the maximal expression of the levels of CD69 activating surface antigen, both in the presence or in the absence of proliferative activity, did not evoke any additional hightening of pADPRP mRNA levels. Time course of PBMC stimulation with a non-mitogenic dose of TPA showed an early increase in the accumulation of pADPRP mRNA, which changed at 8-16 h, and remained high for several days thereafter. On the basis of these data, we suggest that the increase in pADPRP mRNA may be associated with the commitment of human lymphocytes from a quiescent (G0) to an activated (G1) state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551438     DOI: 10.1016/0014-5793(92)80327-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Anti-CD4 monoclonal antibodies in rheumatoid arthritis.

Authors:  E H Choy; G H Kingsley; G S Panayi
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells.

Authors:  M Bhatia; J B Kirkland; K A Meckling-Gill
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

Review 3.  Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.

Authors:  Raffaela Zaffini; Giovanni Gotte; Marta Menegazzi
Journal:  Drug Des Devel Ther       Date:  2018-02-12       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.